Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Chemical Penetration Enhancers

Author(s):  Newton Stephen J

Issue:  Sep/Oct 2013 - Volume 17, Number 5
View All Articles in Issue

Page(s):  370-374

Chemical Penetration Enhancers Page 1
Chemical Penetration Enhancers Page 2
Chemical Penetration Enhancers Page 3
Chemical Penetration Enhancers Page 4
Chemical Penetration Enhancers Page 5

Download in electronic PDF format for $75

Abstract:  Chemical penetration enhancers are utilized in topical preparations as a method for enhancing permeation of drugs across the skin. In particular, they are utilized for transdermal delivery of medications in an attempt to produce a systemic response, to avoid first-pass metabolism, and to decrease the gastrointestinal transit time observed with oral medications. A review of the selection of chemical penetration enhancers, their mechanism of action, the most common chemical penetration enhancers in each class, and alternatives will be discussed in detail.

Related Keywords: Stephen J. Newton, RPh, topical preparation, transdermal penetration, dermal administration, skin, cutaneous absorption, ethanol, isopropyl myristate, oleic acid, emu oil, azone, propylene glycol, decyl methyl sulfoxide, NDMS, dimethyl sulfoxide, DMSO, limonene, urea, carbamide, water, dimethylformamide, DMF, pyrrolidones, NMP, soft enhancement of percutaneous absorption, SEPA

Related Categories: EXCIPIENTS, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Chemical Penetration Enhancers
Newton Stephen J
Sep/Oct 2013
Pg. 370-374

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O
, Light Bob
Nov/Dec 2017
Pg. 530-535

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh
, Baltzley Sarah, AlGhananeem Abeer
Nov/Dec 2018
Pg. 498-503

Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
Jan/Feb 2003
Pg. 48-50

In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie
, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014
Pg. 512-515

Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations
Goodwin Donald A
, Fuhram L Clifton
Nov/Dec 1999
Pg. 496-500

Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan
, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014
Pg. 504-511

Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel
, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2013
Pg. 247-253

Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo.
Allen Loyd V Jr
Mar/Apr 2004
Pg. 107-109

The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J
, Asbill Scott
Nov/Dec 2009
Pg. 569-571

Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit
, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2020
Pg. 168-175

Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS
, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2014
Pg. 256-261

A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
Nov/Dec 2004
Pg. 458-460

Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408

Feline Transdermal Formulation Considerations
Forsythe Lauren Eichstadt
Nov/Dec 2017
Pg. 446-452

Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M
, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015
Pg. 152-160

Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time
Heustess Allie
, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Mar/Apr 2015
Pg. 167-173

Considerations for Percutaneous Absorption
Newton Stephen J
, Cook Jennifer M
Jul/Aug 2010
Pg. 301-304

Return to Top